DiBenedetti D, Kosa K, Waters HC, Oberdhan D. Understanding patients' experiences with borderline personality disorder: qualitative interviews. Neuropsychiatr Dis Treat. 2023 Oct 9;19:2115-25. doi: 10.2147/NDT.S423882
Montserrat-Capdevila J, Seminario MA, Godoy P, Marsal JR, Ortega M, Pujol J, Castan MT, Alseda M, Betriu A, Lecube A, Portero M, Purroy F, Valdivielso JM, Barbe F. Prevalence of chronic obstructive pulmonary disease (COPD) not diagnosed in a population with cardiovascular risk factors. Med Clin (Barc). 2018 Nov 21;151(10):383-9. doi: 10.1016/j.medcli.2017.12.018
Imagawa H, Nagar SP, Montgomery W, Nakamura T, Sato M, Davis KL. Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine. Neuropsychiatr Dis Treat. 2018 Feb 22;14:611-21. doi: 10.2147/NDT.S150261
Novick D, Montgomery W, Aguado J, Peng XM, Haro JM. Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients. Neuropsychiatr Dis Treat. 2016 Apr 11;12:795-800. doi: 10.2147/NDT.S90134
Wheeler SB, Kohler RE, Reeder-Hayes KE, Goyal RK, Lich KH, Moore A, Smith TW, Melvin CL, Muss HB. Endocrine therapy initiation among Medicaid-insured breast cancer survivors with hormone receptor-positive tumors. J Cancer Surviv. 2014 Dec;8(4):603-10. doi: 10.1007/s11764-014-0365-3
Coles T, Coon C, DeMuro C, McLeod LD, Gnanasakthy A. Psychometric evaluation of the Sheehan Disability Scale in adult patients with attention-deficit/hyperactivity disorder. Neuropsychiatr Dis Treat. 2014 May 19;10:887-95. doi: 10.2147/NDT.S55220. eCollection 2014
Bernfort L, Brodtkorb T. QALY som effektmått inom vården : möjligheter och begränsningar. Linköping: linköping University Electronic Press. Cmt- Rapport. 2012.
Brodtkorb T. National system for assessment, prioritization and introduction of non-pharmaceutical health technologies, a pilot study. Cmt- Rapport. 2010.
Rebordosa C, Aguilera C. Safety of antiepileptic drugs during pregnancy. Med Clin (Barc). 2004 May 8;122(17):675-6.
Vallano A, Fortuny J, Arnau JM, Laporte JR. Generic drug prescription at discharge from a hospital emergency service. Med Clin (Barc). 2003 Nov 15;121(17):645-9. doi: 10.1016/s0025-7753(03)74048-2
Fortuny J, Agusti A. Secondary prevention of acute myocardial infarction: should oral anticoagulants and platelet antiaggregants be administered on a combined basis? Med Clin (Barc). 2003 Oct 4;121(11):433-5. doi: 10.1016 / S0025-7753 (03) 73977-3
Ascaso C, Garcia-Esteve L, Navarro P, Aguado J, Ojuel J, Tarragona MJ. Prevalencia de la depresión postparto en las madres españolas: comparación de la estimación mediante la entrevista clínica estructurada y la escala de depresión postparto de Edimburgo. Med Clin (Barc). 2003 Mar 15;120(9):326-9. doi: 10.1157 / 13044232
Pladevall-Vila M, Gabriel R, Yanez A, Sanchez LM, Sobrino J, Marquez E. Therapeutic compliance interventions: a clinical trial. Med Clin (Barc). 2001;116(Suppl 2):63-7.
Arana A, Piero P. Validity of a quick method to identify e. coli and proteae in urine samples. Med Clin (Barc). 1994 Jan;693. doi: 10.1016/j.ahj.2013.12.006
Rivero E, Carrillo E, Portella E, Hernández I, Colom D. Evaluation of the design and reliability of a questionnaire to identify elderly individuals in need for social and health services. Med Clin (Barc). 1993 Dec;101(18):688-92.
Brotons C, Rué M, Rivero E, Pérez G. Tendencies of mortality from cardiovascular diseases in Catalonia: 1975-1992. Med Clin (Barc). 1993 Nov 13;101(16):604-8.
Walker AM, Garcia Rodriguez LA, Perez GS. Epidemiology and the pharmaceutical industry [La epidemiología y la industria farmacéutica]. Med Clin (Barc). 1992 Mar 28;98(12):465-8.